These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 20816115)

  • 1. Usefulness of primary angioplasty in nonagenarians with acute myocardial infarction.
    Danzi GB; Centola M; Pomidossi GA; Consonni D; De Matteis S; Stabile A; Sesana M; Anzuini A; Sganzerla P; Cortese B; Migliorini A; Antoniucci D
    Am J Cardiol; 2010 Sep; 106(6):770-3. PubMed ID: 20816115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time to treatment and three-year mortality after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction-a DANish Trial in Acute Myocardial Infarction-2 (DANAMI-2) substudy.
    Maeng M; Nielsen PH; Busk M; Mortensen LS; Kristensen SD; Nielsen TT; Andersen HR;
    Am J Cardiol; 2010 Jun; 105(11):1528-34. PubMed ID: 20494656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modalities of treatment and 30-day outcomes of unselected patients older than 75 years with acute ST-elevation myocardial infarction: data from the BLITZ study.
    De Luca L; Bolognese L; Casella G; Savonitto S; Gonzini L; Di Chiara A; De Servi S; Notaristefano S; Valagussa L; Maggioni AP; Chiarella F;
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1045-51. PubMed ID: 18799968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use and outcomes of multivessel percutaneous coronary intervention in patients with acute myocardial infarction complicated by cardiogenic shock (from the EHS-PCI Registry).
    Bauer T; Zeymer U; Hochadel M; Möllmann H; Weidinger F; Zahn R; Nef HM; Hamm CW; Marco J; Gitt AK
    Am J Cardiol; 2012 Apr; 109(7):941-6. PubMed ID: 22236463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective evaluation of early abciximab and primary percutaneous intervention for patients with ST elevation myocardial infarction complicated by cardiogenic shock: results of the REO-SHOCK trial.
    Zeymer U; Tebbe U; Weber M; Vohringer HF; Jaksch R; Bischoff KO; Toepel W; Marsalek P; Horn S; Neuhaus KL;
    J Invasive Cardiol; 2003 Jul; 15(7):385-9. PubMed ID: 12840235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracoronary versus intravenous administration of abciximab in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: the comparison of intracoronary versus intravenous abciximab administration during emergency reperfusion of ST-segment elevation myocardial infarction (CICERO) trial.
    Gu YL; Kampinga MA; Wieringa WG; Fokkema ML; Nijsten MW; Hillege HL; van den Heuvel AF; Tan ES; Pundziute G; van der Werf R; Hoseyni Guyomi S; van der Horst IC; Zijlstra F; de Smet BJ
    Circulation; 2010 Dec; 122(25):2709-17. PubMed ID: 21098442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative early and late outcomes after primary percutaneous coronary intervention in ST-segment elevation and non-ST-segment elevation acute myocardial infarction (from the CADILLAC trial).
    Cox DA; Stone GW; Grines CL; Stuckey T; Zimetbaum PJ; Tcheng JE; Turco M; Garcia E; Guagliumi G; Iwaoka RS; Mehran R; O'Neill WW; Lansky AJ; Griffin JJ;
    Am J Cardiol; 2006 Aug; 98(3):331-7. PubMed ID: 16860018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No reflow in patients undergoing primary angioplasty for acute myocardial infarction at high risk: incidence and predictive factors.
    Romano M; Buffoli F; Lettieri C; Aroldi M; Tomasi L; Baccaglioni N; Rosiello R; Zanini R
    Minerva Cardioangiol; 2005 Feb; 53(1):7-14. PubMed ID: 15788976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of ST-segment resolution after primary angioplasty on outcomes after myocardial infarction in elderly patients: an analysis from the CADILLAC trial.
    Prasad A; Stone GW; Aymong E; Zimetbaum PJ; McLaughlin M; Mehran R; Garcia E; Tcheng JE; Cox DA; Grines CL; Gersh BJ;
    Am Heart J; 2004 Apr; 147(4):669-75. PubMed ID: 15077083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of stents and abciximab on survival from cardiogenic shock treated with percutaneous coronary intervention.
    Huang R; Sacks J; Thai H; Goldman S; Morrison DA; Barbiere C; Ohm J
    Catheter Cardiovasc Interv; 2005 May; 65(1):25-33. PubMed ID: 15800889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should patients in cardiogenic shock undergo rescue angioplasty after failed fibrinolysis: comparison of primary versus rescue angioplasty in cardiogenic shock patients.
    Kunadian B; Vijayalakshmi K; Dunning J; Thornley AR; Sutton AG; Muir DF; Wright RA; Hall JA; de Belder MA
    J Invasive Cardiol; 2007 May; 19(5):217-23. PubMed ID: 17476036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ability to achieve complete revascularization is associated with improved in-hospital survival in cardiogenic shock due to myocardial infarction: Manitoba cardiogenic SHOCK Registry investigators.
    Hussain F; Philipp RK; Ducas RA; Elliott J; Džavík V; Jassal DS; Tam JW; Roberts D; Garber PJ; Ducas J
    Catheter Cardiovasc Interv; 2011 Oct; 78(4):540-8. PubMed ID: 21547996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shock index: a simple clinical parameter for quick mortality risk assessment in acute myocardial infarction.
    Bilkova D; Motovska Z; Widimsky P; Dvorak J; Lisa L; Budesinsky T
    Can J Cardiol; 2011; 27(6):739-42. PubMed ID: 21944278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of infarct related artery patency after early abciximab administration on one-year mortality in patients with ST-segment elevation myocardial infarction (data from the EUROTRANSFER Registry).
    Rakowski T; Siudak Z; Dziewierz A; Birkemeyer R; Janzon M; Mielecki W; Zmudka K; Dubiel JS; Dudek D
    Kardiol Pol; 2012; 70(3):215-21. PubMed ID: 22430397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left ventricular function after ST-elevation myocardial infarction in patients treated with primary percutaneous coronary intervention and abciximab or tirofiban (from the Facilitated Angioplasty with Tirofiban or Abciximab [FATA] Trial).
    Taglieri N; Saia F; Guiducci V; Tondi S; Conrotto F; Marrozzini C; Rocchi G; Biagini E; Reggiani ML; Giacometti P; Piovaccari G; Manari A; Marzocchi A;
    Am J Cardiol; 2009 Mar; 103(6):785-90. PubMed ID: 19268732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. When is door-to-balloon time critical? Analysis from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) and CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trials.
    Brodie BR; Gersh BJ; Stuckey T; Witzenbichler B; Guagliumi G; Peruga JZ; Dudek D; Grines CL; Cox D; Parise H; Prasad A; Lansky AJ; Mehran R; Stone GW
    J Am Coll Cardiol; 2010 Jul; 56(5):407-13. PubMed ID: 20650362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracoronary compared to intravenous Abciximab and high-dose bolus compared to standard dose in patients with ST-segment elevation myocardial infarction undergoing transradial primary percutaneous coronary intervention: a two-by-two factorial placebo-controlled randomized study.
    Bertrand OF; Rodés-Cabau J; Larose E; Rinfret S; Gaudreault V; Proulx G; Barbeau G; Déry JP; Gleeton O; Manh-Nguyen C; Noël B; Roy L; Costerousse O; De Larochellière R;
    Am J Cardiol; 2010 Jun; 105(11):1520-7. PubMed ID: 20494655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-hospital time to treatment of patients with acute ST elevation myocardial infarction treated with primary angioplasty: determinants and outcome. Results from the registry of percutaneous coronary interventions in acute myocardial infarction of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausarzte.
    Zahn R; Vogt A; Zeymer U; Gitt AK; Seidl K; Gottwik M; Weber MA; Niederer W; Mödl B; Engel HJ; Tebbe U; Senges J;
    Heart; 2005 Aug; 91(8):1041-6. PubMed ID: 16020592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of late survival in patients with cardiogenic shock due to right ventricular infarction versus left ventricular pump failure following primary percutaneous coronary intervention for ST-elevation acute myocardial infarction.
    Brodie BR; Stuckey TD; Hansen C; Bradshaw BH; Downey WE; Pulsipher MW
    Am J Cardiol; 2007 Feb; 99(4):431-5. PubMed ID: 17293178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reperfusion by primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction within 12 to 24 hours of the onset of symptoms (from a prospective national observational study [PL-ACS]).
    Gierlotka M; Gasior M; Wilczek K; Hawranek M; Szkodzinski J; Paczek P; Lekston A; Kalarus Z; Zembala M; Polonski L
    Am J Cardiol; 2011 Feb; 107(4):501-8. PubMed ID: 21195380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.